Oxford AstraZeneca jabs effective against severe COVID new trial in US confirms
A large trial in the US and two South American countries of the Oxford-AstraZeneca vaccine has shown 79 per cent efficacy rate at…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Mene Pangalos
CEO says AstraZeneca likely to run new global trial of COVID-19 vaccine
AstraZeneca shot developed with Oxford University is cheaper to make, easier to distribute and faster to scale up than its rivals